Vaccine Delivery Devices Market

Vaccine Delivery Devices Market Size

[COVID-19 SERIES] The vaccine delivery devices market is estimated to be worth $1.5 billion by 2030, driven by the increase in global vaccination coverage. According to experts, the global vaccines market is anticipated to generate revenues worth USD 100 billion by 2025.

To learn more about this report, request a free sample copy

Data presented by the WHO indicates that the current global vaccination coverage is nearly 85%; this is believed to be responsible for preventing close to three million deaths from diseases, such as diphtheria, tetanus, whooping cough and measles. Recent global immunization records indicate that more than 115 million children were immunized against diphtheria, tetanus and pertussis in 2018. Given the rate at which the global population is growing, the demand for vaccines is likely to increase significantly. However, biopharmaceutical developers are plagued by concerns related to storage and handling of such preventive / therapeutic products. One commonly reported issue is related to vaccine administration. Despite the success of conventional delivery approaches, which rely on the intramuscular and subcutaneous routes of administration, the present scenario dictates that further improvements are required in order to deal with challenges related to large scale immunization initiatives. Some of the commonly reported disadvantages of the conventional (parenteral) mode of delivery include pain during administration, risk of cross contamination, needlestick injuries, and inaccurate dosing. 

Tap or click on the images for smart insights on Vaccine Delivery Devices Market

Of late, there has been an evident shift in interest to non-invasive immunization methods, which include oral, intranasal and transdermal modes of administration. Currently, many biopharmaceutical companies and clinical research institutes are engaged in the development of novel vaccine drug delivery system, taking into consideration the specific requirements of large scale immunization initiatives. As a result, significant efforts have been put into the development of drug delivery technologies / devices, such as needle free drug delivery devices, electroporation-based needle free vaccine injection systems, jet injectors, inhalation-based delivery systems, biodegradable implants and certain novel types of oral delivery systems. It is worth highlighting that most of the aforementioned systems are specifically being designed to facilitate pain-free administration of vaccines and allow self-administration. Additionally, these novel vaccine delivery devices can play an important role in vaccination during the event  of disease outbreaks / pandemics (such as the one being faced due to the novel coronavirus / COVID-19), where medical centers may not be equipped to deal with large scale immunization campaigns. Vaccine developers are also attempting to devise ways to make such products more stable so as to eliminate the need for healthcare cold chain logistics in transporting such products. Given the pace of innovation in this field, it is anticipated that the novel vaccine delivery devices market is likely to witness a considerable market growth during the forecast period.

Tap or click on the images for smart insights on Vaccine Delivery Devices Market

Key Companies in Vaccine Delivery Devices Market

Examples of key companies engaged in vaccine delivery devices market (which have also been profiled in this market report; the complete list of companies is available in the full report) include 3M, Becton Dickinson, Consort Medical, D'Antonio Consultants International, Enesi Pharma, Ichor Medical Systems, Iconovo, Inovio Pharmaceuticals, PharmaJet and Union Medico. This market report includes an easily searchable excel database of all the companies providing vaccine delivery devices, worldwide.

Recent Developments in Vaccine Delivery Devices Market

Several recent developments have taken place in the field of vaccine delivery devices market. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.

• In February 2026, SK bioscience, IDT Biologika, and Vaxxas announced selection for a collaborative project to develop next-generation influenza vaccine using advanced delivery technologies, targeting the premium European seasonal influenza vaccine market for older adults with innovative devices.
• In January 2026, Pfizer entered into a licensing agreement with Novavax worth up to $530 million for Novavax's Matrix-M adjuvant technology used in vaccine delivery.
• In September 2025, Apiject Systems submitted a New Drug Application to the FDA for its innovative single-dose, single-use prefilled plastic syringe injection device, marking the world's first such injectable medicine for improved vaccine and drug delivery.
• In November 2025, Dynavax entered into a license agreement with Vaxart for its novel oral COVID-19 vaccine program, paying $25 million upfront and $5 million equity investment.

Tap or click on the images for smart insights on Vaccine Delivery Devices Market

Scope of the Vaccine Delivery Devices Market Report

The “Novel Vaccine Delivery Devices Market: Industry Trends and Global Forecasts, till 2035” market report features an extensive study of the current market landscape, market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics and future opportunities of the vaccine delivery devices market.

Amongst other elements, the market research report includes:

• A detailed assessment of the overall novel vaccine delivery devices market landscape, featuring an elaborate list of device developers and analysis based on a number of relevant parameters, such as year of establishment, company size, geographical location, type of device (autoinjectors, microneedle patches, jet injectors, dry powder inhalers, microinjectors, nasal delivery systems, pen injectors, biodegradable implants, electroporation-based needle free vaccine injection systems and novel oral delivery systems), route of administration (subcutaneous, transdermal, intramuscular, intradermal, inhalation, intranasal, and oral), drug delivery mechanism (mechanical, electrical and miscellaneous), nature of vaccine administration (invasive and non-invasive), speed of administration (fast, moderate and slow), self- administration potential, provisions for audio / visual feedback, device usability (disposable and reusable), type of needle (needleless, fixed needle, detachable needle, and hidden needle), and current development status of novel vaccine drug delivery system (preclinical / discovery, clinical and marketed).
• A detailed competitiveness analysis of novel vaccine delivery devices, taking into consideration the supplier power (based on the year of establishment of developer company) and key product specifications (such as route of administration, device usability, drug delivery mechanism, availability of needle safety system, speed of administration, self-administration potential, provisions for audio / visual feedback, nature of administration, cold chain requirement and current status of development).
• An analysis evaluating the effectiveness of various vaccines delivery devices in order to compare their respective strengths and capabilities based on a variety of relevant parameters, such as type of active ingredient, dosage form, route of administration, target disease indication and target patient population.
• A detailed list of marketed and pipeline vaccine candidates that are anticipated to be developed in combination with novel vaccine delivery devices in the near future, featuring analysis based on parameters, such as type of active ingredient, dosage form, route of administration, target disease indication and target patient population. 
• Elaborate profiles of prominent product developers engaged in vaccine delivery devices market; each profile features a brief overview of the company, its financial information (if available), information on its product portfolio, recent developments and an informed future outlook.
• An analysis of recent collaborations and partnership agreements inked in vaccine delivery devices market since 2014, including details of deals that were / are focused on novel vaccine delivery devices. The partnerships captured in the report were analyzed on the basis of year of establishment, type of agreement, type of device, type of vaccine, type of active ingredient and target disease indication.
• A discussion on important, industry-specific trends, key market drivers and challenges, under a comprehensive SWOT framework, featuring a qualitative Harvey ball analysis that highlights the relative impact of each SWOT parameter on the overall market.

The key objective of vaccine delivery devices market report is to provide a detailed market analysis in order to estimate the existing market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics and future opportunity for vaccine delivery devices market during the forecast period. Based on various parameters, such as number of marketed / pipeline products, price of devices (for commercially available products only) and estimated annual adoption rate, we have developed an informed estimate on the likely evolution of the market over the forecast period, till 2030. In addition, we have provided the likely distribution of the current and forecasted opportunities across [A] type of device (electroporation-based needle free vaccine injection systems, oral delivery systems, nasal delivery systems, jet injectors, microneedle patches and microinjectors), [B] route of administration (oral, intramuscular, intranasal, intradermal and subcutaneous), [C] type of vaccine (Bivalent Oral Polio Vaccine, BCG Vaccine, DTP-HepB-Hib Vaccine, Pneumococcal Conjugate Vaccine, Influenza Vaccine, Measles Vaccine, Tetanus-Diphtheria Vaccine and Others) and [D] key geographical regions (North America, Europe, Asia and rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.

The opinions and insights presented in the market report were influenced by discussions held with senior stakeholders in vaccine delivery devices market. The market research report features detailed transcripts of interviews held with the following industry stakeholders:

• Michael Schrader, Chief Executive Officer and Founder, Vaxess Technologies
• Mikael Ekstrom and Roger Lassing, Vice President, Business Development, Iconovo
• Henry King, Market Intelligence and Business Development Manager, Innoture

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this market research report are in USD, unless otherwise specified.